BioLife Solutions, Inc. (BLFS): Price and Financial Metrics
BLFS Price/Volume Stats
| Current price | $17.19 | 52-week high | $24.50 |
| Prev. close | $17.02 | 52-week low | $8.92 |
| Day low | $16.90 | Volume | 522,800 |
| Day high | $18.02 | Avg. volume | 411,354 |
| 50-day MA | $17.36 | Dividend yield | N/A |
| 200-day MA | $15.31 | Market Cap | 778.71M |
BLFS Stock Price Chart Interactive Chart >
BioLife Solutions, Inc. (BLFS) Company Bio
BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company was founded in 1987 and is based in Bothell, Washington.
Latest BLFS News From Around the Web
Below are the latest news stories about BIOLIFE SOLUTIONS INC that investors may wish to consider to help them evaluate BLFS as an investment opportunity.
Analysts Just Shaved Their BioLife Solutions, Inc. (NASDAQ:BLFS) Forecasts DramaticallyThe analysts covering BioLife Solutions, Inc. ( NASDAQ:BLFS ) delivered a dose of negativity to shareholders today, by... |
BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales CyclesConestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […] |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call TranscriptBioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst Conference Call. At this time, all participants […] |
BioLife Solutions Reports Third Quarter 2023 Financial ResultsBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and nine months of 2023. |
BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter financial results will be released after market close on Thursday, November 9, 2023. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business upda |
BLFS Price Returns
| 1-mo | -5.03% |
| 3-mo | -1.66% |
| 6-mo | 84.05% |
| 1-year | -4.39% |
| 3-year | -49.26% |
| 5-year | 2.08% |
| YTD | 5.78% |
| 2023 | -10.71% |
| 2022 | -51.17% |
| 2021 | -6.57% |
| 2020 | 146.54% |
| 2019 | 34.50% |
Continue Researching BLFS
Want to do more research on Biolife Solutions Inc's stock and its price? Try the links below:Biolife Solutions Inc (BLFS) Stock Price | Nasdaq
Biolife Solutions Inc (BLFS) Stock Quote, History and News - Yahoo Finance
Biolife Solutions Inc (BLFS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...